Fosun Group and Shanghai Pharma place interest in Arbor Pharmaceuticals

By Catherine Sturman
Fosun Group and Shanghai Pharmaceuticals have recently stated their interest in bidding for a stake in US company Arbor Pharmaceuticals. One of the lar...

Fosun Group and Shanghai Pharmaceuticals have recently stated their interest in bidding for a stake in US company Arbor Pharmaceuticals.

One of the largest pharmaceutical group’s in China, Fosun Group focuses on the production of new medicines which are exported worldwide, whilst utilising exceptional technologies within its research and development facilities. In a stock exchange filing, it has been revealed that the company’s potential stake in Arbor has been financially backed by private equity firm KKR & Co LP, according to Reuters.

On the same day, Shanghai Pharma also placed its bid. Dually listed on the stock exchange in Shanghai and Hong Kong, the company has retained its position as a leader within manufacturing and distribution of chemical and bio-pharmaceutical products within China, and has partnered with a number of universities across the country.

Related stories

Both companies are looking at acquiring a 20-30% stake in Arbor, according to those who are familiar with the deal. The company has also bought Bank of American Merrill Lynch on board to help ensure any potential sale goes smoothly.

Arbor Pharmaceuticals markets prescription products for “cardiovascular, hospital, neuroscience and paediatric markets,” supplying prescription drugs such as edarbi, cetylev, horizant and evekeo.

Share

Featured Articles

A new perspective on autism support with modern technology

Dr Louise Morpeth, CEO at Brain in Hand, discusses new technologies for autism support & creating better access for people with autism to access healthcare

Efficient communications can reduce hospital emergencies

Roni Jamesmeyer, Senior Healthcare Manager at Five9, explains how proactive communications can reduce emergency situations in hospitals & support patients

Promoting equality and diversity to increase economic growth

As businesses report the benefits of equality, we explore global barriers for women & LGBTQ+ individuals & the impact on their wellbeing

Global Population Health Summit took place in New York

Hospitals

MEDSIR research closer to ‘the end of chemotherapy’

Medical Devices & Pharma

5 minutes with Sonia Powar, BGF’s Healthcare Investments

Digital Healthcare